S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
MarketBeat Week in Review – 12/4 - 12/8
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
MarketBeat Week in Review – 12/4 - 12/8
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
MarketBeat Week in Review – 12/4 - 12/8
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
MarketBeat Week in Review – 12/4 - 12/8

Eiger BioPharmaceuticals (EIGR) News Today

$0.31
-0.01 (-3.17%)
(As of 12/8/2023 ET)
Compare
Today's Range
$0.30
$0.34
50-Day Range
$0.22
$0.43
52-Week Range
$0.21
$2.98
Volume
100,997 shs
Average Volume
150,934 shs
Market Capitalization
$13.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.67
SourceHeadline
yahoo.com logo‘Bob Eiger’ Trends on X After Elon Musk Blasts the Disney CEO With Multi-Tweet Typo
yahoo.com - December 7 at 7:16 PM
MarketBeat logoEiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Sees Large Decrease in Short Interest
americanbankingnews.com - December 5 at 3:50 AM
finance.yahoo.com logoEiger BioPharmaceuticals Insiders US$2.1m Short Of Breakeven On Stock Purchase
finance.yahoo.com - December 4 at 9:11 AM
MarketBeat logoEiger BioPharmaceuticals (NASDAQ:EIGR) Coverage Initiated by Analysts at StockNews.com
americanbankingnews.com - December 3 at 4:46 AM
finanznachrichten.de logoEiger BioPharmaceuticals, Inc.: Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
finanznachrichten.de - November 11 at 8:10 AM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Ocular Therapeutix (OCUL), Eiger Biopharmaceuticals (EIGR)
markets.businessinsider.com - September 15 at 7:32 AM
marketwatch.com logoEiger BioPharmaceuticals Shares Hit New Lows After Scrapped Hepatitis D Study
marketwatch.com - September 13 at 6:38 PM
markets.businessinsider.com logoEiger To Discontinue Peginterferon Lambda Trial In CHD Patients; Stock Down In Premarket
markets.businessinsider.com - September 13 at 6:38 PM
msn.com logoWhy Is Hepatitis Player Eiger BioPharma Stock Trading Lower Today?
msn.com - September 13 at 6:38 PM
investorplace.com logoWhy Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?
investorplace.com - September 13 at 10:02 AM
reuters.com logoEiger to discontinue late-stage hepatitis drug study over safety concerns
reuters.com - September 13 at 2:38 AM
news.yahoo.com logoEiger to discontinue hepatitis drug study over safety concerns
news.yahoo.com - September 12 at 9:37 PM
marketwatch.com logoEiger BioPharmaceuticals to Discontinue Chronic Hepatitis Delta Study, Ends Licensing Talks
marketwatch.com - September 12 at 9:37 PM
seekingalpha.com logoEiger to stop late stage trial in hepatitis D patients, stock slumps ~36% after hours
seekingalpha.com - September 12 at 9:37 PM
finance.yahoo.com logoUPDATE 1-Eiger to discontinue hepatitis drug study over safety concerns
finance.yahoo.com - September 12 at 9:37 PM
reuters.com logoEiger to discontinue hepatitis drug study
reuters.com - September 12 at 4:28 PM
marketbeat.com logo
marketbeat.com - September 12 at 4:04 PM
markets.businessinsider.com logoCiti Sticks to Their Buy Rating for Eiger Biopharmaceuticals (EIGR)
markets.businessinsider.com - August 30 at 6:47 AM
finanznachrichten.de logoEiger BioPharmaceuticals, Inc.: Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
finanznachrichten.de - August 15 at 5:52 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Eiger Biopharmaceuticals (EIGR) and Atossa Therapeutics (ATOS)
markets.businessinsider.com - August 15 at 5:52 PM
markets.businessinsider.com logoEiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
markets.businessinsider.com - August 14 at 8:55 PM
yahoo.com logoFreewell Eiger matte box aims to transform your filmmaking
yahoo.com - August 3 at 1:36 PM
msn.com logoEiger BioPharmaceuticals (EIGR) Price Target Decreased by 59.60% to 3.40
msn.com - July 6 at 8:48 PM
msn.com logoBaird Maintains Eiger BioPharmaceuticals (EIGR) Outperform Recommendation
msn.com - July 1 at 1:18 PM
markets.businessinsider.com logoPotential Upside For Eiger's Avexitide In Both PBH And CHI Indications: Analyst
markets.businessinsider.com - June 30 at 3:41 PM
msn.com logoEiger cuts 25% of staff in portfolio reorganization
msn.com - June 29 at 3:55 PM
msn.com logoEiger BioPharmaceuticals Makes Interim CEO Permanent, It Chalks Out Portfolio Prioritization Review, Layoffs
msn.com - June 29 at 3:55 PM
markets.businessinsider.com logoEiger Biopharmaceuticals (EIGR) Gets a Buy from Ladenburg Thalmann & Co.
markets.businessinsider.com - June 29 at 3:55 PM
finance.yahoo.com logoEiger BioPharmaceuticals to Host Business Update Call Tomorrow
finance.yahoo.com - June 28 at 6:59 PM
finance.yahoo.com logoEiger BioPharmaceuticals Slides As Insider Purchases Lose Another US$81k
finance.yahoo.com - June 27 at 9:01 AM
fool.com logoEiger BioPharmaceuticals (NASDAQ: EIGR)
fool.com - June 1 at 9:49 PM
finance.yahoo.com logoInvestors Holding Back On Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR)
finance.yahoo.com - May 31 at 10:06 AM
msn.com logoRecap: Eiger BioPharmaceuticals Q1 Earnings
msn.com - May 11 at 8:17 PM
finance.yahoo.com logoEiger BioPharmaceuticals (NASDAQ:EIGR) adds US$9.4m to market cap in the past 7 days, though investors from five years ago are still down 88%
finance.yahoo.com - May 4 at 8:07 AM
markets.businessinsider.com logoEiger Biopharmaceuticals (EIGR) Receives a Buy from BTIG
markets.businessinsider.com - April 3 at 7:53 AM
finance.yahoo.com logoSome Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Analysts Just Made A Major Cut To Next Year's Estimates
finance.yahoo.com - March 31 at 8:17 AM
markets.businessinsider.com logoLadenburg Thalmann & Co. Reaffirms Their Buy Rating on Eiger Biopharmaceuticals (EIGR)
markets.businessinsider.com - March 21 at 8:05 AM
markets.businessinsider.com logoRobert W. Baird Sticks to Its Buy Rating for Eiger Biopharmaceuticals (EIGR)
markets.businessinsider.com - March 20 at 12:55 PM
msn.com logoEiger BioPharmaceuticals Earnings Perspective: Return On Capital Employed
msn.com - March 20 at 12:55 PM
finance.yahoo.com logoLoss-Making Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Expected To Breakeven In The Medium-Term
finance.yahoo.com - March 18 at 10:36 AM
seekingalpha.com logoEiger BioPharmaceuticals GAAP EPS of -$0.57 misses by $0.03, revenue of $2.69M misses by $1.73M
seekingalpha.com - March 17 at 1:14 AM
finance.yahoo.com logoEiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
finance.yahoo.com - March 16 at 8:03 PM
benzinga.com logoEiger BioPharmaceuticals Stock (NASDAQ:EIGR), Dividends
benzinga.com - March 13 at 8:39 PM
seekingalpha.com logoEiger BioPharmaceuticals: The Results Are In - The CEO And The CFO Are Out
seekingalpha.com - February 19 at 5:13 PM
finance.yahoo.com logoEiger BioPharma's Single Dose Of Peginterferon Lambda Cuts Risk Of COVID-19-Related Hospitalizations, Deaths
finance.yahoo.com - February 17 at 2:25 AM
msn.com logoEiger gains as journal publishes late-stage data on COVID therapy
msn.com - February 9 at 7:50 AM
finance.yahoo.com logoNew England Journal of Medicine Publishes Positive Phase 3 TOGETHER Results with Peginterferon Lambda in COVID-19
finance.yahoo.com - February 8 at 8:57 PM
benzinga.com logoFINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
benzinga.com - January 9 at 2:15 PM
benzinga.com logoCLASS ACTION UPDATE for EIGR, SGLY and SUNL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
benzinga.com - January 6 at 6:35 PM
technews.tmcnet.com logoThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR)
technews.tmcnet.com - January 6 at 1:34 PM
Get Eiger BioPharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EIGR and its competitors with MarketBeat's FREE daily newsletter.



EIGR Media Mentions By Week

EIGR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EIGR
News Sentiment

0.25

0.51

Average
Medical
News Sentiment

EIGR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EIGR Articles
This Week

4

1

EIGR Articles
Average Week

Get Eiger BioPharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EIGR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:EIGR) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -